HB6512 combines a series of health‑policy changes intended to shift federal subsidy flows, expand tax‑preferred consumer accounts, loosen rules for alternative group and individual market products, and restrict federal financing for abortion and gender‑transition interventions.
The bill creates a Health Freedom Waiver Program that lets states waive core Affordable Care Act requirements if they maintain a high‑risk pool, and requires the federal government to redirect the premium tax credit and cost‑sharing reduction (CSR) dollars that would have gone to exchange plans into new “Trump Health Freedom Accounts” (a special HSA variant). It also alters HSA and employer‑sponsored plan rules, authorizes expanded association health plans and CHOICE HRAs, establishes a limited reinsurance program, tightens exchange enrollment and verification rules, and imposes a categorical federal prohibition on funding abortion and a long list of gender‑transition procedures.
At a Glance
What It Does
Allows states to waive many ACA exchange rules (including IRC §§36B and 5000A) if they maintain a high‑risk program and redirects the aggregate premium tax credit/CSR amounts into a new HSA‑style account for eligible residents. It revises Health Savings Account rules, authorizes association health plans and CHOICE arrangements, creates a federal reinsurance pot, and bans federal payment for abortion and defined gender‑transition care.
Who It Affects
State insurance regulators and governors (who can file for waivers); insurers that sell individual or association plans; employers (especially small or self‑employed groups) that may shift to CHOICE or AHP products; tax officials and plan administrators who must implement Trump Health Freedom Accounts; exchange operators required to tighten verification; and providers and patients of abortion and gender‑transition services.
Why It Matters
The bill redesigns how federal subsidy dollars flow (from insurer payments to deposits into individual accounts), potentially fragmenting risk pools and changing insurer product incentives. It imposes immediate compliance and product‑design shifts for insurers and employers while legally restricting federal support for categories of clinical care that many plans currently cover.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill sets up a new Health Freedom Waiver Program (section labeled 1335) that lets a governor or state legislature notify HHS and Treasury—90 days before the plan year—requesting waivers of specific ACA rules for plan years starting January 1, 2026, provided the state keeps a high‑risk pool or comparable risk‑mitigation program. A core operational change is “money follows the person”: if a waiver means residents no longer qualify for premium tax credits or CSRs through exchange mechanisms, the Secretary must calculate the aggregate credit/CSR amounts those residents would have received (using a national silver benchmark among non‑waiver states) and deposit that money into a Trump Health Freedom Account (a limited HSA variant) on behalf of each eligible resident.
Individuals can receive such payments monthly, quarterly, or as a lump sum.
The bill overhauls HSA rules: it opens HSA contributions to people entitled to Medicare Part A by age, allows both spouses to make catch‑up contributions to the same HSA, creates rules to convert or roll FSA/HRA balances into HSAs, clarifies pre‑establishment qualified expense treatment, raises special contribution limits for higher‑income filers (with an explicit phase‑out), and carves out Trump Health Freedom Accounts from many rollover/transfer rules. Importantly, Trump Health Freedom Accounts are explicitly prohibited from paying for abortion or a detailed list of gender‑transition procedures.On the group side, HB6512 revives and expands association health plan (AHP) rules and creates CHOICE arrangements (employer HRAs integrated with individual coverage) that the statute treats as meeting certain PHSA nondiscrimination and benefit‑design requirements.
It also protects an employer’s ability to purchase stop‑loss insurance for self‑funded plans and directs preemption language to ensure stop‑loss availability. To encourage employers to offer CHOICE arrangements, the bill creates a temporary employer tax credit for establishing such arrangements.The bill also intervenes in exchanges and the individual market: it tightens open enrollment timing (sets a November 1–December 15 annual window for plan years starting in 2027), restricts the availability and scope of special enrollment periods, requires more robust verification of income and eligibility (and links advance premium tax credit eligibility to an individual’s tax‑filing and reconciliation status), and removes some automatic enrollment rules that move people from bronze to silver plans.
It establishes a $50‑per‑member‑month federal reinsurance appropriation capped at $6 billion annually for 2026–2030, sets a large attachment point and high payment proportion for 2026, and requires price‑transparency and out‑of‑network cost‑counting rules intended to steer patients toward lower‑cost providers.Finally, Title III creates a statutory ban on federal funding for abortion and for a broad list of gender‑transition procedures. The abortion provisions add a new title 1 chapter prohibiting federal funds for any abortion and bar federal funds (including credits and CSRs) from going to plans that include abortion coverage (with narrow life‑of‑the‑mother and rape/incest exceptions).
The gender provision defines a lengthy list of hormonal and surgical interventions as prohibited from federal funding and applies that ban to federal programs and to the Trump Health Freedom Accounts.
The Five Things You Need to Know
States may waive major ACA exchange provisions (specified parts of subtitle D, §1402, and IRC §§36B & 5000A) for plan years starting Jan 1, 2026, if they maintain a high‑risk pool and file notice at least 90 days before participation.
The Secretary must redirect the aggregate premium tax credits and cost‑sharing reductions that would have gone to exchange enrollees in waiver states into individual Trump Health Freedom Accounts, using a national average silver benchmark among non‑waiver states to calculate payments.
Trump Health Freedom Accounts are IRS‑defined HSA variants that recipients may receive monthly, quarterly, or in a lump sum, but the accounts are statutorily barred from funding abortion or a long, specific list of gender‑transition procedures.
The bill sets a November 1–December 15 standard open enrollment for plan years beginning in 2027, restricts special enrollment periods, requires expanded income verification, and ties eligibility for advance premium tax credits to timely tax filing and reconciliation.
Title III creates an explicit federal prohibition on taxpayer funding of abortion and a broad set of gender‑transition procedures (with limited exceptions for rape, incest, and life‑saving treatment) and requires separate disclosure where plans do cover abortion.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
State waivers of key ACA requirements and ‘money follows the person’
This section permits states (governor or majority legislative vote) to request waivers of specified ACA provisions — including parts of subtitle D, the CSR provision §1402, and Internal Revenue Code sections that underpin the individual mandate and premium tax credits — for plan years beginning January 1, 2026, provided the state maintains an ‘invisible’ high‑risk pool or comparable risk‑mitigation program. The waiver application is administrative (90‑day pre‑notice, evidence of risk‑mitigation), and HHS/Treasury must build a coordinated waiver processing route so states can submit a single application across multiple federal laws.
New HSA‑style accounts funded by redirected subsidy dollars
The bill adds an IRS subsection creating a Trump Health Freedom Account: when a waiver results in individuals losing eligibility for exchange premium tax credits or CSRs, the Secretary must compute what those residents would have received and deposit that aggregate amount into individual Trump accounts. The Secretary computes these payments using the national average silver benchmark among non‑waiver states; recipients choose monthly, quarterly, or lump‑sum receipt. The statute treats these accounts as the individual’s only HSA and bars their use to pay premiums or services related to abortion or enumerated gender‑transition procedures, while allowing certain limited rollovers and requiring new IRS compliance rules.
Expanded HSA eligibility, catch‑ups, conversions, and contribution increases
HB6512 expands HSA eligibility (including individuals entitled to Medicare Part A by age), lets both spouses make catch‑up contributions to the same HSA, and creates rules to let FSA/HRA balances be contributed to an HSA when an employee first establishes HDHP coverage. The bill also clarifies pre‑establishment expense treatment, allows certain spouses to contribute when the other has an FSA, raises HSA contribution limits for specified taxpayers (with a phased reduction keyed to adjusted gross income), and adjusts inflation indexing timing for the new dollar limits.
Broadening alternative employer plans and protecting stop‑loss
The bill revives and expands association health plan rules — treating qualifying employer associations as ‘employers’ for ERISA purposes, specifying governance, nondiscrimination, and solvency traits, and allowing different actuarial premium treatments for employer members. It also creates CHOICE arrangements (employer HRAs integrated with individual market coverage) and treats certain CHOICE HRAs as meeting PHSA requirements if they satisfy notice, substantiation, and nondiscrimination rules. The Self‑Insurance Protection Act clarifies that stop‑loss policies bought by self‑funded sponsors are not ‘health insurance’ and instructs preemption language to protect stop‑loss availability across States.
Federal reinsurance for certain off‑exchange plans and price‑transparency rules
The bill establishes a Reinsurance Program to subsidize high claims for covered off‑exchange individual plans (issuers electing out of the single risk pool), funded at $50 per member month with a $6 billion annual cap (2026–2030). Secretary must set attachment point/payment proportion (2026: $110,000 attach, 90% payment, $300,000 cap). It also requires plans and providers to disclose lower in‑network or other price options and lets patients apply some out‑of‑network costs toward in‑network deductibles when the non‑contract provider’s charge is at or below low benchmarks.
Shortened open enrollment, restricted special SEP use, and stronger verification
For plan years beginning in 2027 the bill fixes the annual exchange open enrollment to Nov 1–Dec 15, limits special enrollment periods tied to income, forces Exchanges to verify eligibility for most SEP enrollments, and pressures Exchanges to verify income when tax‑data are unavailable or inconsistent. Critically, it conditions advance premium tax credit determinations on an applicant’s tax‑filing and reconciliation history and removes automatic extensions and some reenrollment conveniences, plus reduces initial advance credit amounts for certain reenrolled individuals who have not updated eligibility.
Statutory ban on federal funding of abortion and related plan restrictions
Title III adds a new chapter to title 1 U.S.C. that bars the expenditure of any federally authorized or appropriated funds (and funds in trust funds) for any abortion and for health benefits that include abortion coverage. The statute preserves narrow exceptions for rape, incest, and life‑saving care, allows separate non‑federally funded abortion coverage if paid entirely with non‑federal funds, and requires separate notice/disclosure when plans do include abortion services and any premium surcharges attributable to those services.
Comprehensive statutory ban on federal funding for a broad list of gender‑transition procedures
The bill defines a lengthy list of hormonal and surgical interventions as ‘specified sex‑trait modification procedures’ and prohibits federal funds (grants, contracts, insurance payments, federal program payments) from being used for them. The definition covers puberty blockers, cross‑sex hormones at supra‑physiologic doses, castration, hysterectomy, mastectomy, phalloplasty/metoidioplasty/vaginoplasty, voice surgery, augmentation mammoplasty, implants, liposuction and other procedures described in the text; it allows limited medical exceptions (disorders of sex development, urgent life‑saving treatment) but is otherwise broadly drafted.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- States seeking market flexibility — the waiver option gives governors/legislatures a statutory path to opt out of specified ACA mandates if they provide a high‑risk program, enabling new product mixes and state‑level subsidy designs.
- Consumers who prefer account‑based subsidies — individuals in waiver states receive subsidy dollars directly into Trump Health Freedom Accounts (monthly/quarterly/lump sum), increasing consumer control over how subsidy dollars are spent.
- Employers and the self‑employed — CHOICE arrangements, expanded association health plan rules, and a clarified stop‑loss preemption make self‑funding and association models more practicable, and a temporary employer credit lowers start‑up costs for CHOICE arrangements.
- Insurers selling alternative, off‑exchange products — the reinsurance appropriation and the ability to opt out of a single pooled risk approach for certain individual products create revenue opportunities for issuers that structure offerings outside exchange pooled obligations.
- Health care sharing ministries and faith‑based alternatives — the bill explicitly treats health‑sharing ministry fees and memberships as eligible medical expenditures under HSAs and HSAs‑like accounts, increasing their tax‑preferred access.
Who Bears the Cost
- Patients seeking abortion or gender‑transition care — the federal funding ban and explicit prohibitions in Trump Health Freedom Accounts mean many federal subsidies and plans cannot cover those services, reducing coverage access unless paid entirely with non‑federal funds.
- Health insurers that offer plans covering abortion or gender‑transition services — carriers risk losing CSR funding, may be excluded from receiving certain federal payments, and face new disclosure and underwriting constraints.
- Exchanges and state regulators — they must implement new verification systems, enforce tighter SEP rules and income checks, process waiver applications, and handle redirected subsidy payments into new account mechanisms.
- Providers of gender‑transition services and some reproductive providers — revenue from federally subsidized plans and federal programs could be curtailed, shifting payer mix and potentially reducing service availability.
- Consumers exposed to fragmented risk pools — if many states opt for waivers, insurers will face segmentation and potential premium volatility, and some consumer protections (market‑wide pooling incentives) could be less effective.
Key Issues
The Core Tension
The central dilemma is classic: increase consumer choice and portability by moving federal subsidies into individual accounts and loosening product rules, or preserve broad, pooled protections and comprehensive coverage financed via the exchanges. HB6512 favors choice and accountability but does so by weakening pooling, restricting covered services, and reallocating federal dollars in ways that could raise premiums for some and reduce coverage for others; regulators and courts will be asked to reconcile those competing policy goals.
The bill packs many moving parts whose real‑world outcomes hinge on regulation and implementation choices. The ‘money follows the person’ construct pays each eligible resident an amount tied to a national average silver premium among non‑waiver states; whether that benchmark under‑ or overcompensates local costs will drive insurer pricing and whether networks retreat or expand in waiver states.
The Secretary has delegated rulemaking duties (for the waiver program, reinsurance operation, HSA rules and CHOICE arrangements) that will determine how much practical flexibility states, insurers, and employers actually gain.
The statutory ban on federal funding for abortion and a very broad list of gender‑transition procedures creates compliance and carve‑out complexities. The text allows separate, purely private coverage for those services but simultaneously restricts employer and exchange subsidy flows and requires detailed disclosure of abortion surcharges; administering and policing the boundary between federal and non‑federal funding will be operationally and legally fraught.
The gender‑transition definition includes many common interventions; clinical exceptions are limited and may not map neatly to standard medical practice, raising medical‑necessity disputes and litigation risk. Finally, many ERISA, PHSA, and state insurance law interactions are implicated — the bill asserts preemption in stop‑loss contexts and expands employer plan models, but litigation over preemption, guaranteed issue, and essential health benefit boundaries is likely.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.